A. T. Borchers, C. A. Aoki, S. M. Naguwa, C. L. Keen, Y. Shoenfeld et al., Neuropsychiatric Features of Systemic Lupus Erythematosus, Autoimmunity Reviews, vol.4, issue.6, pp.329-373, 2005.

G. Lefèvre, H. Zéphir, E. Michelin, F. Semah, F. Warembourg et al., Diagnostic and treatment tools in psychiatric or central nervous system manifestations in systemic lupus erythematosus, La Revue De Medecine Interne, vol.33, issue.9, pp.503-516, 2012.

, The American College of Rheumatology Nomenclature and Case Definitions for Neuropsychiatric Lupus Syndromes, Arthritis and Rheumatism, vol.42, issue.4, pp.599-608, 1999.

M. Hochberg, Updating the American College of Rheumatology Revised Criteria for the Classification of Systemic Lupus Erythematosus, Arthritis and Rheumatism, vol.40, issue.9, p.1725, 1997.

M. Petri, A. Orbai, G. S. Alarcón, C. Gordon, J. T. Merrill et al., Derivation and Validation of the Systemic Lupus International Collaborating Clinics Classification Criteria for Systemic Lupus Erythematosus, Arthritis and Rheumatism, vol.64, issue.8, pp.2677-86, 2012.

. J. Thompsona, B. L. Banwell, F. Barkhof, W. M. Carroll, T. Coetzee et al., Diagnosis of Multiple Sclerosis: 2017 Revisions of the McDonald Criteria, The Lancet. Neurology, vol.17, issue.2, pp.162-73, 2018.

D. M. Wingerchuk, B. Banwell, J. L. Bennett, P. Cabre, W. Carroll et al., International Consensus Diagnostic Criteria for Neuromyelitis Optica Spectrum Disorders, Neurology, vol.85, issue.2, pp.177-89, 2015.

D. D. Gladman, D. Ibañez, and U. M. , Systemic Lupus Erythematosus Disease Activity Index, The Journal of Rheumatology, vol.29, issue.2, pp.288-91, 2000.

J. G. Hanly, E. Kozora, S. Beyea, and J. Birnbaum, Nervous System Disease in Systemic Lupus Erythematosus: Current Status and Future Directions, Arthritis & Rheumatology

J. Hanly, Diagnosis and Management of Neuropsychiatric SLE, Nature Reviews. Rheumatology, vol.10, issue.6, pp.338-385, 2014.

L. A. Degiorgio, K. N. Konstantinov, S. C. Lee, J. A. Hardin, B. T. Volpe et al., A Subset of Lupus Anti-DNA Antibodies Cross-Reacts with the NR2 Glutamate Receptor in Systemic Lupus Erythematosus, Nature Medicine, vol.7, issue.11, pp.1189-93, 2001.

M. Govoni, S. Bombardieri, A. Bortoluzzi, L. Caniatti, C. Casu et al., Factors and Comorbidities Associated with First Neuropsychiatric Event in Systemic Lupus Erythematosus: Does a Risk Profile Exist? A Large Multicentre Retrospective Cross-Sectional Study on 959 Italian Patients, Rheumatology, vol.51, issue.1, pp.157-68, 2012.

J. G. Hanly, M. B. Urowitz, J. Sanchez-guerrero, S. C. Bae, C. Gordon et al., Neuropsychiatric Events at the Time of Diagnosis of Systemic Lupus Erythematosus: An International Inception Cohort Study, Arthritis and Rheumatism, vol.56, issue.1, pp.265-73, 2007.

G. Lefèvre, H. Zéphir, F. Warembourg, E. Michelin, J. Pruvo et al., Neuropsychiatric systemic lupus erythematosus (1st part). Cases definitions and diagnosis and treatment of central nervous system and psychiatric manifestations of systemic lupus erythematosus, La Revue De Medecine Interne, vol.33, issue.9, pp.491-502, 2012.

A. Unterman, J. E. Nolte, M. Boaz, M. Abady, Y. Shoenfeld et al., Neuropsychiatric Syndromes in Systemic Lupus Erythematosus: A Meta-Analysis, Seminars in Arthritis and Rheumatism, vol.41, issue.1, pp.1-11, 2011.

P. P. Sfikakis, D. D. Mitsikostas, M. N. Manoussakis, D. Foukaneli, and M. H. , Headache in Systemic Lupus Erythematosus: A Controlled Study, British Journal of Rheumatology, vol.37, issue.3, pp.300-303, 1998.

R. Davey, J. Bamford, and E. P. , The ACR Classification Criteria for Headache Disorders in SLE Fail to Classify Certain Prevalent Headache Types, Cephalalgia: An International Journal of Headache, vol.28, issue.3, pp.296-99, 2008.

D. D. Mitsikostas, P. P. Sfikakis, and P. J. Goadsby, A Meta-Analysis for Headache in Systemic Lupus Erythematosus: The Evidence and the Myth, Brain: A Journal of Neurology, vol.127, pp.1200-1209, 2004.

G. K. Bertsias, J. P. Ioannidis, M. Aringer, E. Bollen, S. Bombardieri et al., EULAR Recommendations for the Management of Systemic Lupus Erythematosus with Neuropsychiatric Manifestations: Report of a Task Force of the EULAR Standing Committee for Clinical Affairs, Annals of the Rheumatic Diseases, vol.69, issue.12, pp.2074-82, 2010.

C. C. Mok, C. S. Lau, and R. W. Wong, Neuropsychiatric Manifestations and Their Clinical Associations in Southern Chinese Patients with Systemic Lupus Erythematosus, The Journal of Rheumatology, vol.28, issue.4, pp.766-71, 2001.

E. Harboe, A. B. Tjensvoll, S. Maroni, L. G. Gøransson, O. J. Greve et al., Neuropsychiatric Syndromes in Patients with Systemic Lupus Erythematosus and Primary Sjögren Syndrome: A Comparative Population-Based Study, Annals of the Rheumatic Diseases, vol.68, issue.10, pp.1541-1587, 2009.

J. G. Hanly, M. B. Urowitz, L. Su, S. Bae, C. Gordon et al., Autoantibodies as Biomarkers for the Prediction of Neuropsychiatric Events in Systemic Lupus Erythematosus, Annals of the Rheumatic Diseases, vol.70, issue.10, pp.1726-1758, 2011.

J. G. Hanly, M. B. Urowitz, F. Siannis, V. Farewell, C. Gordon et al., Autoantibodies and Neuropsychiatric Events at the Time of Systemic Lupus Erythematosus Diagnosis: Results from an International Inception Cohort Study, Arthritis and Rheumatism, vol.58, issue.3, pp.843-53, 2008.

H. Ainiala, A. Hietaharju, J. Loukkola, J. Peltola, M. Korpela et al., Validity of the New American College of Rheumatology Criteria for Neuropsychiatric Lupus Syndromes: A Population-Based Evaluation, Arthritis and Rheumatism, vol.45, issue.5, pp.419-442, 2001.

A. Bortoluzzi, C. A. Scirè, S. Bombardieri, L. Caniatti, F. Conti et al., Development and Validation of a New Algorithm for Attribution of Neuropsychiatric Events in Systemic Lupus Erythematosus, Rheumatology, vol.54, issue.5, pp.891-98, 2015.

F. Cotton, J. Bouffard-vercelli, M. Hermier, J. Tebib, D. Durand et al., [MRI of central nervous system in a series of 58 systemic lupus erythematosus (SLE) patients with or without overt neuropsychiatric manifestations, La Revue De Medecine Interne, vol.25, issue.1, pp.8-15, 2004.

O. Nived, . Sturfelt, M. H. Liang, D. Pablo, and P. , The ACR Nomenclature for CNS Lupus Revisited, Lupus, vol.12, issue.12, pp.872-76, 2003.

S. Sciascia, M. L. Bertolaccini, S. Baldovino, D. Roccatello, M. A. Khamashta et al., Central Nervous System Involvement in Systemic Lupus Erythematosus: Overview on Classification Criteria, Autoimmunity Reviews, vol.12, issue.3, pp.426-455, 2013.

T. M. Netto, N. Zimmermann, F. Rueda-lopes, B. C. Bizzo, R. P. Fonseca et al., Neuropsychiatric Lupus: Classification Criteria in Neuroimaging Studies, The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques, vol.40, issue.3, pp.284-91, 2013.

M. Postal, T. Lapa, A. Reis, F. Rittner, L. Appenzeller et al., Magnetic Resonance Imaging in Neuropsychiatric Systemic Lupus Erythematosus: Current State of the Art and Novel Approaches, Lupus, vol.26, issue.5, pp.517-538, 2017.

J. G. Hanly, M. B. Urowitz, L. Su, J. Sanchez-guerrero, S. C. Bae et al., Short-Term Outcome of Neuropsychiatric Events in Systemic Lupus Erythematosus upon Enrollment into an International Inception Cohort Study, Arthritis and Rheumatism, vol.59, issue.5, pp.721-750, 2008.

V. Fernandes-moça-trevisani, A. A. Castro, J. Ferreira-neves-neto, and A. A. , Cyclophosphamide versus Methylprednisolone for Treating Neuropsychiatric Involvement in Systemic Lupus Erythematosus, The Cochrane Database of Systematic Reviews, issue.2, p.2265, 2013.

L. Barile-fabris, R. Ariza-andraca, L. Olguín-ortega, L. J. Jara, A. Fraga-mouret et al., Controlled Clinical Trial of IV Cyclophosphamide versus IV Methylprednisolone in Severe Neurological Manifestations in Systemic Lupus Erythematosus, Annals of the Rheumatic Diseases, vol.64, issue.4, pp.620-645, 2005.

L. Stojanovich, R. Stojanovich, V. Kostich, and D. E. , Neuropsychiatric Lupus Favourable Response to Low Dose I.v. Cyclophosphamide and Prednisolone (Pilot Study), Lupus, vol.12, issue.1, pp.3-7, 2003.

D. Marra, Z. Amoura, N. Soussan, J. Haroche, A. Consoli et al., Plasma Exchange in Patients with Stuporous Catatonia and Systemic Lupus Erythematosus, Psychotherapy and Psychosomatics, vol.77, issue.3, pp.195-96, 2008.